ENDOVASC LTD INC
NT 10-K, 2000-09-29
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: ENDOVASC LTD INC, 10KSB, EX-27, 2000-09-29
Next: ENDOVASC LTD INC, NT 10-K/A, 2000-09-29



                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 12b-25

                        Commission File Number: 000-28371

                           NOTIFICATION OF LATE FILING

|X| Form 10-K |_| Form 11-K |_| Form 20-F |_| Form 10-Q
|_| Form N-SAR

         For Period Ended:          June 30, 2000

|_| Transition Report on Form 10-K |_| Transition Report on Form 10-Q
|_| Transition Report on Form 20-F |_| Transition Report on Form N-SAR

For the Transition Period Ended: _______________________________________

     Nothing in this form shall be  construed to imply that the  Commission  has
verified any information contained herein.

     If the  notification  relates  to a portion of the  filing  checked  above,
indentify the item(s) to which the notification relates:________________________


                                     PART I
                             REGISTRANT INFORMATION

Full name of registrant                     Endovasc Ltd., Inc.
Former name if applicable
Address of principal executive office       15001 Walden Road, Suite 108
City, state and zip code                    Montgomery, Texas 77356

                                     PART II
                             RULE 12b-25 (b) AND (c)

         If the subject report could not be filed without unreasonable effort or
expense and the  registrant  seeks  relief  pursuant  to Rule  12b-25  (b),  the
following should be completed. (Check box if appropriate.)

              (a)           The  reasons  described in reasonable detail in Part
                            III of  this  form  could  not be eliminated without
                            unreasonable effort or expense;
              (b)           The  subject  annual  report,   semi-annual  report,
                            transition  report on Form 10-K,  20-F, 11-K or Form
                            10-Q,  or portion  therof will be filed on or before
                            the 15th calendar day following the prescribed   due
|X|                         date; or the subject quarterly report or  transition
                            report  on  Form  10-Q,  or  portion thereof will be
                            filed  on or before the fifth calendar day following
                            the prescribed due date; and
              (c)           The accountant's statement or other exhibit required
                            by Rule 12b-25(c) has been attached if applicable.


<PAGE>
                              Part III - Narrative

         The compilation,  dissemination and review of the information  required
to be  presented  in the Form  10-K for the  relevant  fiscal  year has  imposed
logistical  constraints  that  have  rendered  timely  filing  of the Form  10-K
impracticable  without undue hardship and expense. The registrant undertakes the
responsibility  to file such annual  report no later than fifteen days after its
original date.

                           Part IV--Other Information

     (1) Name and  telephone  number  of  person  to  contact  in regard to this
notification

David Summers                             (936)                448-2222
        (Name)                       (Area Code)          (Telephone Number)

     (2) Have all other periodic  reports  required under Section 13 or 15(d) of
the Securities  Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940  during the  preceding  12 months or for such  shorter  period  that the
registrant was required to file such report(s) been filed?  If the answer is no,
identify report(s).

                                 [X] Yes [ ] No


     (3) Is it anticipated that any significant  change in results of operations
from the corresponding  period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?

                                 [ ] Yes [X] No




<PAGE>
                                    SIGNATURE

         Pursuant to the  requirements  of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the Undersigned, thereunto duly authorized.

                                                Endovasc Ltd., Inc.
                                                  (Registrant)




Dated:  September 29, 2000                  /s/ David Summers
                                            By: David Summers
                                                Chief Executive Officer


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission